| Literature DB >> 34054305 |
Li Zhang1, Yirui Hu2, Xianren Wu1, Michael J Paglia3, Xiaopeng Zhang1.
Abstract
PURPOSE: Compared to low concentrations of local anesthetics with opioids for labor epidural analgesia, very high concentrations of local anesthetics are associated with an increased risk of assisted vaginal delivery. We aimed to investigate if moderately high concentrations of plain local anesthetics are also associated with this risk.Entities:
Keywords: assisted vaginal delivery; epidural; labor analgesia; local anesthetics; meta-analysis
Year: 2021 PMID: 34054305 PMCID: PMC8154542 DOI: 10.2147/JPR.S305838
Source DB: PubMed Journal: J Pain Res ISSN: 1178-7090 Impact factor: 3.133
Figure 1Flow chart for literature enrollment from identification to final synthesis according to the PRISMA protocol.
Baseline Characteristics of Included Clinical Trials
| Sample Size | Drugs | Dose | Mode of Maintenance | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Studies | Region | Population | Local | Local + Opioids | Local | Local + Opioids | Local | Local + Opioids | |
| Chestnut 1988 | USA | Nulliparous | 39 | 41 | 0.125% bupivacaine | 0.0625% bupivacaine + 2 µg/mL of fentanyl | 12.5 mL/hour | 12.5 mL/hour | Continuous infusion with clinician bolus |
| Rodriguez 1990 | USA | Mixed | 16 | 16 | 0.125% bupivacaine | 0.0625% bupivacaine + 20 µg/mL of butorphanol | 12 mL/hour | 12 mL/hour | Continuous infusion with clinician bolus |
| Bailey 1994 | UK | Mixed | 25 | 25 | 0.125% bupivacaine | 0.0625% bupivacaine + 5 µg/mL of diamorphine | 10 mL/hour | 10 mL/hour | Continuous infusion with clinician bolus |
| Ferrer Gomez 2000 | Spain | Mixed | 42 | 42 | 0.2% ropivacaine | 0.1% ropivacaine + 2 µg/mL of fentanyl | 6 to 10 mL/hour | 6 to 10 mL/hour | Continuous infusion with clinician bolus |
| Dresner 2000 | UK | Mixed | 102 | 101 | 0.2% ropivacaine | 0.1% bupivacaine + 2 µg/mL of fentanyl | 8 mL/hour | 8 mL/hour | Continuous infusion with clinician bolus |
| Lee 2002 | China | Nulliparous | 19 | 20 | 0.2% ropivacaine | 0.1% ropivacaine + 2 µg/mL of fentanyl | 10 mL/hour | 10 mL/hour | Continuous infusion with clinician bolus |
| Reynolds 2003 | UK | Mixed | 296 | 291 | 0.125% bupivacaine | 0.0625% bupivacaine + 2.5 µg/mL of fentanyl or 0.25 µg/mL of sufentanil | 12 mL/hour | 12 mL/hour | Continuous infusion with clinician bolus |
| Khan 2004 | India | Mixed | 25 | 25 | 0.125% bupivacaine | 0.0625% bupivacaine + 1 µg/mL of fentanyl | 8 mL/hour | 8 mL/hour | Continuous infusion |
| Gogarten 2004 | Belgium and Germany | Mixed | 106 | 103 | 0.2% ropivacaine | 0.125% ropivacaine + 0.75 µg/mL of sufentanil | 4 mL bolus with a lockout interval of 15 minutes | 4 mL bolus with a lockout interval of 15 minutes | Patient controlled epidural analgesia without background infusion |
Figure 2Forest plot of odds of assisted vaginal delivery (A), Cesarean delivery (B), and spontaneous vaginal delivery (C). There are no significant differences between the group of moderately high concentrations of plain local anesthetics and the group of low concentrations of local anesthetics with opioids.
Figure 3Forest plot of duration of first stage (A) and second stage of labor (B). Moderately high concentrations of local anesthetics are associated with a small but significant decrease in the duration of first stage of labor but no significant change in the duration of second stage of labor.
Maternal Pain Score and Pain Relief
| Sample Size | Timing of Assessment | Pain Scores | Pain Relief | ||||
|---|---|---|---|---|---|---|---|
| Studies | Region | Population | Local | Local + Opioids | Local versus Local + Opioids | Local versus Local + Opioids | |
| Chestnut 1988 | USA | Nulliparous | 39 | 41 | 0, 15, 30 minutes after the test dose, and then every 30 minutes. | No difference | No difference |
| Rodriguez 1990 | USA | Mixed | 16 | 16 | 15, 30, 45, 60 minutes after the initial dose, and then every 30 minutes. | No difference | No difference |
| Bailey 1994 | UK | Mixed | 25 | 25 | 30 minutes after the test dose, and then every 60 minutes. | No difference | NA |
| Ferrer Gomez 2000 | Spain | Mixed | 42 | 42 | 0, 5, 10, 15, 30, 60, 90, 120 minutes after the initial dose. | Slightly higher pain scores at 15, 30, 60, 90 minutes in Local group; no difference at other times | NA |
| Dresner 2000 | UK | Mixed | 102 | 101 | 30 minutes after the initial dose. Scores for first and second stage obtained 24 hours after delivery. | No difference | No difference |
| Lee 2002 | China | Nulliparous | 19 | 20 | 0, 10, 20, 30, 60 minutes after the initial dose, and then every 60 minutes. | No difference | NA |
| Khan 2004 | India | Mixed | 25 | 25 | 15, 30, 60, 90 minutes after the initial dose. | Slightly lower pain score at 30 minutes in Local group; no difference at other times | NA |
| Gogarten 2004 | Belgium and Germany | Mixed | 106 | 103 | 0, 10, 20, 60 minutes after the initial dose, and then every 60 minutes. | No difference | NA |
Figure 4Forest plot of maternal side effects including motor block (A), pruritus (B), nausea (C), vomiting (D), maternal hypotension (E) and urinary retention (F). Moderately high concentrations of local anesthetics are associated with increased odds of motor block but decreased odds of pruritus. There are no significant differences in nausea, vomiting, maternal hypotension or urinary retention between the two groups.
Figure 5Forest plot of neonatal Apgar scores at one minute (A) and five minutes (B), and neonatal umbilical arterial blood pH (C). There are no significant differences in Apgar scores or umbilical arterial blood pH between the two groups.